Legend Number of Employees

LEGN Stock

USD 48.22 0.22 0.46%

Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Current Assets Total Assets

Legend Number of Employees Analysis

Legend BiotechCorp's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

	2020	2021	2022	2023 (projected)
Interest Expense	4.21 M	900 K	1.03 M	1.33 M
Gross Profit	75 M	68.83 M	79.15 M	78.27 M

Interest Expense Gross Profit

Number of Employees

Full Time

Part Time

More About Number of Employees | All Equity Analysis

Current Legend BiotechCorp Number of Employees

1.07 K

Most of Legend BiotechCorp's fundamental indicators, such as Number of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Legend Number of Employees Driver Correlations

Understanding the fundamental principles of building solid financial models for Legend BiotechCorp is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Number of Employees. Since Legend BiotechCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend BiotechCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend BiotechCorp's interrelated accounts and indicators.

	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Deferred Revenue	Shareholders Equity	Investments Current	Total Liabilities	Current Liabilities	Tax Assets	Tax Liabilities
Total Assets		1.0	0.97	0.94	0.64	0.86	0.98	0.91	0.97	0.97	-0.76	-0.76
Current Assets	1.0		0.97	0.94	0.64	0.86	0.98	0.91	0.97	0.97	-0.75	-0.75
Cash and Equivalents	0.97	0.97		0.97	0.69	0.92	0.99	0.93	0.97	0.95	-0.82	-0.82
Total Debt	0.94	0.94	0.97		0.55	0.89	0.93	0.99	0.98	0.97	-0.84	-0.84
Debt Current	0.64	0.64	0.69	0.55		0.78	0.67	0.41	0.56	0.48	-0.48	-0.48
Deferred Revenue	0.86	0.86	0.92	0.89	0.78		0.88	0.83	0.89	0.83	-0.91	-0.91
Shareholders Equity	0.98	0.98	0.99	0.93	0.67	0.88		0.91	0.94	0.94	-0.78	-0.78
Investments Current	0.91	0.91	0.93	0.99	0.41	0.83	0.91		0.97	0.97	-0.83	-0.83
Total Liabilities	0.97	0.97	0.97	0.98	0.56	0.89	0.94	0.97		0.99	-0.84	-0.84
Current Liabilities	0.97	0.97	0.95	0.97	0.48	0.83	0.94	0.97	0.99		-0.8	-0.8
Tax Assets	-0.76	-0.75	-0.82	-0.84	-0.48	-0.91	-0.78	-0.83	-0.84	-0.8		1.0
Tax Liabilities	-0.76	-0.75	-0.82	-0.84	-0.48	-0.91	-0.78	-0.83	-0.84	-0.8	1.0

Click cells to compare fundamentals

Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.

Competition

Predict Legend BiotechCorp

Based on the recorded statements, Legend BiotechCorp is currently employing 1.07 K people. This is 90.26% lower than that of the Healthcare sector and 100.05% higher than that of the Biotechnology industry. The number of employees for all United States stocks is 94.32% higher than that of the company.

Legend Number of Employees Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend BiotechCorp's direct or indirect competition against its Number of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend BiotechCorp could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics of similar companies.

Legend BiotechCorp is currently under evaluation in number of employees category among related companies.

Legend Fundamentals

	Return On Equity	(0.97) %
	Return On Asset	(0.26) %
	Operating Margin	(3.29) %
	Current Valuation	8.02 B
	Shares Outstanding	167.4 M
	Shares Owned by Insiders	1.36 %
	Shares Owned by Institutions	38.67 %
	Number of Shares Shorted	5.11 M
	Price to Book	19.80 X
	Price to Sales	73.18 X
	Revenue	89.79 M
	Gross Profit	91.56 M
	EBITDA	(385.31 M)
	Net Income	(386.21 M)
	Cash and Equivalents	791.26 M
	Cash per Share	5.11 X
	Total Debt	120.46 M
	Debt to Equity	0.29 %
	Current Ratio	3.83 X
	Book Value Per Share	3.63 X
	Cash Flow from Operations	(198.47 M)
	Short Ratio	9.52 X
	Earnings Per Share	(3.14) X
	Target Price	70.89
	Number of Employees	1.07 K
	Beta	-0.0875
	Market Capitalization	7.85 B
	Total Asset	1.12 B
	Z Score	39.0
	Net Asset	1.12 B

About Legend BiotechCorp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pair Correlation Now

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments

All Next

Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.

	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Probability Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	CEO Directory Screen CEOs from public companies around the world
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Global Correlations Find global opportunities by holding instruments from different markets

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.14)

Revenue Per Share

0.788

Quarterly Revenue Growth

(0.42)

Return On Assets

(0.26)

Return On Equity

(0.97)

The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine Legend BiotechCorp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Legend Number of Employees

Legend Number of Employees Analysis

Current Legend BiotechCorp Number of Employees

Legend Number of Employees Driver Correlations

Legend Number of Employees Peer Comparison

Legend Fundamentals

About Legend BiotechCorp Fundamental Analysis

Be your own money manager

Did you try this?

Run Pair Correlation Now

Pair Correlation

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Legend Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY